Cargando…
Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
Major depressive disorder (MDD) is a prevalent neuropsychiatric disease that causes profound social and economic burdens. The impact of MDD is compounded by the limited therapeutic efficacy and delay of weeks to months of currently available medications. These issues highlight the need for more effi...
Autores principales: | Wohleb, Eric S., Gerhard, Danielle, Thomas, Alex, Duman, Ronald S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327447/ https://www.ncbi.nlm.nih.gov/pubmed/26955968 http://dx.doi.org/10.2174/1570159X14666160309114549 |
Ejemplares similares
-
Novel rapid-acting antidepressants: molecular and cellular signaling mechanisms
por: Thomas, Alexandra M., et al.
Publicado: (2017) -
Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms
por: Hare, Brendan D., et al.
Publicado: (2017) -
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
por: Duman, Ronald S.
Publicado: (2018) -
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
por: Browne, Caroline A., et al.
Publicado: (2013) -
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
por: Yang, Chun, et al.
Publicado: (2019)